JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
PUT
Mondelez International
MDLZ
$74.7B
| $4.2M | ﹤0.01% |
83,900
-83,300
| -50% | -$4.51M |
2014 Q2
23 quarters
|
|
2302
Rollins
ROL
$14.3B
| $4.19M | ﹤0.01% |
174,021
+52,056
| +43% | +$1.28M |
2015 Q4
17 quarters
|
|
2303
Flowserve
FLS
$9.44B
| $4.19M | ﹤0.01% |
175,449
+64,932
| +59% | +$2.62M |
2013 Q2
27 quarters
|
|
2304
CALL
Teladoc Health
TDOC
$1.05B
| $4.18M | ﹤0.01% |
27,000
| – | – |
2019 Q4
1 quarter
|
|
2305
SITE Centers
SITC
$170M
| $4.18M | ﹤0.01% |
1,027,403
+535,848
| +109% | +$4.64M |
2013 Q2
27 quarters
|
|
|
DCP
2306
DELISTED
DCP Midstream, LP
DCP
| $4.17M | ﹤0.01% |
1,025,196
+112,085
| +12% | +$1.87M |
2013 Q2
27 quarters
|
|
2307
Vir Biotechnology
VIR
$1.99B
| $4.17M | ﹤0.01% |
121,655
+21,914
| +22% | +$589K |
2019 Q4
1 quarter
|
|
2308
Pinnacle Financial Partners Inc
PNFP
$14.5B
| $4.16M | ﹤0.01% |
110,907
-24,842
| -18% | -$1.35M |
2013 Q2
27 quarters
|
|
2309
Simply Good Foods
SMPL
$879M
| $4.15M | ﹤0.01% |
215,317
-17,815
| -8% | -$390K |
2017 Q4
9 quarters
|
|
2310
CALL
KKR & Co
KKR
$80.8B
| $4.14M | ﹤0.01% |
176,600
-162,300
| -48% | -$4.66M |
2018 Q4
5 quarters
|
|
2311
Sunrun
RUN
$1.83B
| $4.14M | ﹤0.01% |
410,227
+101,960
| +33% | +$1.67M |
2016 Q2
15 quarters
|
|
2312
US Physical Therapy
USPH
$1.25B
| $4.13M | ﹤0.01% |
59,860
+45,691
| +322% | +$4.82M |
2015 Q4
17 quarters
|
|
2313
CALL
American International
AIG
$39.3B
| $4.13M | ﹤0.01% |
170,300
+50,400
| +42% | +$2.16M |
2016 Q4
13 quarters
|
|
2314
Independence Realty Trust
IRT
$3.47B
| $4.13M | ﹤0.01% |
461,991
+135,339
| +41% | +$1.83M |
2016 Q1
16 quarters
|
|
2315
PUT
Lam Research
LRCX
$433B
| $4.13M | ﹤0.01% |
172,000
-846,000
| -83% | -$24.4M |
2019 Q1
4 quarters
|
|
2316
Howard Hughes
HHH
$4.28B
| $4.12M | ﹤0.01% |
85,594
+79,946
| +1,415% | +$8.01M |
2015 Q4
17 quarters
|
|
|
HDV
2317
iShares Core High Dividend ETF
HDV
$14.6B
| $4.12M | ﹤0.01% |
288,025
-195,395
| -40% | -$3.45M |
2013 Q2
27 quarters
|
|
2318
Cabot Corp
CBT
$4B
| $4.12M | ﹤0.01% |
157,799
-4,923
| -3% | -$187K |
2013 Q2
27 quarters
|
|
2319
Goodyear
GT
$1.35B
| $4.12M | ﹤0.01% |
707,588
+318,075
| +82% | +$3.47M |
2013 Q2
27 quarters
|
|
|
LFC
2320
DELISTED
China Life Insurance Company Ltd.
LFC
| $4.12M | ﹤0.01% |
421,894
+13,345
| +3% | +$160K |
2015 Q4
17 quarters
|
|
|
DAY
2321
DELISTED
Dayforce
DAY
| $4.11M | ﹤0.01% |
82,152
-5,996
| -7% | -$397K |
2018 Q2
7 quarters
|
|
|
CHCT
2322
Community Healthcare Trust
CHCT
$383M
| $4.11M | ﹤0.01% |
107,452
+53,613
| +100% | +$2.33M |
2016 Q1
16 quarters
|
|
2323
CALL
Halliburton
HAL
$27.3B
| $4.11M | ﹤0.01% |
600,000
-360,000
| -38% | -$6.27M |
2014 Q3
22 quarters
|
|
|
KDNY
2324
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.1M | ﹤0.01% |
299,396
-54,464
| -15% | -$644K |
2015 Q2
19 quarters
|
|
|
QUOT
2325
DELISTED
Quotient Technology Inc
QUOT
| $4.09M | ﹤0.01% |
629,119
-313,816
| -33% | -$2.8M |
2017 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.